Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders

Journal of Autism and Developmental Disorders

Volumn 30, Issue 5, 2000, Pages 451-459

  Aman, Michael G ^a   Langworthy, Kristen S ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Autism; Hyperactivity; Inattention; Overactivity; PDDNOS; Pharmacotherapy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; AMPHETAMINE; ANXIOLYTIC AGENT; BUSPIRONE; CLOMIPRAMINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; DIAZEPAM; FLUOXETINE; GUANFACINE; LAMOTRIGINE; LEVAMFETAMINE SUCCINATE; METHYLPHENIDATE; NALTREXONE; NEUROLEPTIC AGENT; OPIATE ANTAGONIST; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ATTENTION; AUTISM; CHILD; CHILDHOOD DISEASE; DEVELOPMENTAL DISORDER; DROWSINESS; FEMALE; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; HUMANS; PSYCHOTROPIC DRUGS;

EID: 0033745762     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005559725475     Document Type: Review

References (57)

1. Stimulant drug effects in developmental disorders and hyperactivity: Toward a resolution of disparate findings
2. Stimulant drugs in the developmental disabilities revisited
3. Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use
4. Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms
5. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children
6. Paradoxical excitement to sedative-hypnotic drugs in mentally retarded clients
7. Methylphenidate treatment of hyperactive autistic children
8. A comparison of haloperidol and behavior therapy and their interaction in autistic children
9. Naltrexone in autistic children: Behavioral symptoms and attentional learning
10. Response to tri-iodothyronine and dextroamphetamine: A study of preschool schizophrenic children
11. Naltrexone in autistic children: An acute open dose range tolerance trial
12. Levodopa and levoamphetamine: A crossover study in young schizophrenic children
13. Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial
14. Use of risperidone in pervasive developmental disorders: A case series
15. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism
16. Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity
17. Differential response of seven subjects with autistic disorder to clomipramine and desipramine
18. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder
19. Efficacy of methylphenidate among children with autism and symptoms of ADHD
20. Risperidone and explosive aggressive autism
21. Clonidine treatment of hyperactive and impulsive children with autistic disorder
22. Low-dose neuroleptic therapy for children with childhood-onset pervasive developmental disorder
23. A double blind placebo controlled study of amantadine hydrochloride in treatment of children with autistic disorder
24. Naltrexone in young autistic children: A double bind placebo-controlled crossover study
25. Naltrexone in young autistic children: Replication study and learning measures
26. Factors related to haloperidol response and dyskinesias in autistic children
27. Stimulus over-selectivity in autism: A review of research
28. The action of central nervous system stimulant drugs: A general theory concerning amphetamine effects
29. Olanzapine for autistic disorder with hyperactivity
30. Paradoxical reactions elicited by diazepam in children with classic autism
31. Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study
32. Treatment with buspirone in a patient with autism
33. An open trial of risperidone in young autistic children
34. Behavioral assessment of psychopathology in children: Infantile autism
35. Risperidone in children and adolescents with pervasive developmental disorder: Pilot trial and follow-up
36. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study
37. Use of methylphenidate in the treatment of children with autistic disorder
38. Dextro-amphetamine: Its cognitive and behavioral effects in normal and hyperactive boys and normal men
39. Clinical effect of buspirone in autistic children
40. 'Paradoxical' effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology
41. Paradoxical response to sedative/hypnotics in patients with self-injurious behavior and stereotypy
42. The effect of stimulant medication in childhood-onset pervasive developmental disorder: A case report
43. Use of stimulant medication in treating pervasive developmental disorder
44. Randomized trial of methylphenidate for autistic child
45. Stimulant medication in certain childhood disorders
46. Inappropriate uses of stimulant medications
47. Breadth of attention and retention in mentally retarded and intellectually average children
48. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including nonseizure-related benefits
49. Methylphenidate in hyperactive and enuretic children
50. Anxiolytics, sedatives, and miscellaneous drugs
51. Brief report: Six months continuation treatment in naltrexone-responsive children with autism: An open-label case-control design
52. The effects of chronic naltrexone treatment in young autistic children: A double-blind placebo-controlled crossover study
53. Placebo-controlled acute dosage naltrexone study in young autistic children
54. The role of attention in retardate discrimination learning
55. Clinical effects of clozapine on autistic disorder